On Invalid Date, Olema Pharmaceuticals (NASDAQ: OLMA) reported Q4 2023 earnings per share (EPS) of -$0.48, up 26.15% year over year. Total Olema Pharmaceuticals earnings for the quarter were -$26.77 million. In the same quarter last year, Olema Pharmaceuticals's earnings per share (EPS) was -$0.65.
As of Q2 2024, Olema Pharmaceuticals's earnings has grown year over year. Olema Pharmaceuticals's earnings in the past year totalled -$96.66 million.
What is OLMA's earnings date?
Olema Pharmaceuticals's earnings date is Invalid Date. Add OLMA to your watchlist to be reminded of OLMA's next earnings announcement.
What was OLMA's revenue last quarter?
On Invalid Date, Olema Pharmaceuticals (NASDAQ: OLMA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Olema Pharmaceuticals's revenue was $0.00.
What was OLMA's revenue growth in the past year?
As of Q2 2024, Olema Pharmaceuticals's revenue has grown null year over year. Olema Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.